Rhythm Pharmaceuticals (RYTM) Stock
Rhythm Pharmaceuticals (RYTM) closed at $116.61 on Nov 17, 2026; its Tenet Score is 36 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $116.61
- Nov 17, 2026
- Market cap
- $7.5B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 74.50 – 122.20
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 36/100
- Weak · 340 Healthcare peers
Industry: Drugs
Rhythm Pharmaceuticals Inc. scores 36/100. Weak. Value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent me…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
| Protagonist Therapeutics IncPTGX | 65 | $8.1B |
| Alkermes plcALKS | 37 | $7.8B |
| Corcept Therapeutics IncCORT | 54 | $7.6B |
| Cytokinetics IncCYTK | 34 | $7.4B |
| Kiniksa Pharmaceuticals International Plc.KNSA | 55 | $7.4B |
| Amneal Pharmaceuticals IncAMRX | 39 | $7.4B |
| Axsome Therapeutics IncAXSM | 31 | $7.2B |
| Twist Bioscience CorpTWST | 48 | $7.2B |
| Oruka Therapeutics Inc.ORKA | 54 | $6.7B |
Common questions
What sector and industry is Rhythm Pharmaceuticals in?
Rhythm Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Rhythm Pharmaceuticals' Tenet Score?
Rhythm Pharmaceuticals' Tenet Score is 36 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




